| Developmental pharmacology—drug disposition, action, and therapy in infants and children GL Kearns, SM Abdel-Rahman, SW Alander, DL Blowey, JS Leeder, ... New England Journal of Medicine 349 (12), 1157-1167, 2003 | 2594 | 2003 |
| Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor N Meydan, T Grunberger, H Dadi, M Shahar, E Arpaia, Z Lapidot, ... Nature 379 (6566), 645-648, 1996 | 1049 | 1996 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake … JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ... Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015 | 947 | 2015 |
| The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype A Gaedigk, SD Simon, RE Pearce, LD Bradford, MJ Kennedy, JS Leeder Clinical Pharmacology & Therapeutics 83 (2), 234-242, 2008 | 822 | 2008 |
| Pharmacogenetics of fatal morphine poisoning in a breastfed neonate of a codeine using mother G Koren, J Cairns, D Chitayat, A Gaedigk, SJ Leeder Lancet 368 (9536), 704, 2006 | 761* | 2006 |
| Cytochrome P450 3A: ontogeny and drug disposition SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 37, 485-505, 1999 | 704 | 1999 |
| Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update KR Crews, A Gaedigk, HM Dunnenberger, JS Leeder, TE Klein, ... Clinical Pharmacology & Therapeutics 95 (4), 376-382, 2014 | 700 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, ... Clinical Pharmacology & Therapeutics 98 (1), 19-24, 2015 | 646 | 2015 |
| Prediction of CYP2D6 phenotype from genotype across world populations A Gaedigk, K Sangkuhl, M Whirl-Carrillo, T Klein, JS Leeder Genetics in Medicine 19 (1), 69-76, 2017 | 481 | 2017 |
| Glucuronidation in humans: pharmacogenetic and developmental aspects SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 36, 439-452, 1999 | 479 | 1999 |
| Valproic acid pathway: pharmacokinetics and pharmacodynamics Y Ghodke-Puranik, CF Thorn, JK Lamba, JS Leeder, W Song, ... Pharmacogenetics and genomics 23 (4), 236-241, 2013 | 428 | 2013 |
| The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database A Gaedigk, M Ingelman‐Sundberg, NA Miller, JS Leeder, M Whirl‐Carrillo, ... Clinical Pharmacology & Therapeutics 103 (3), 399-401, 2018 | 382 | 2018 |
| Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case–control study P Madadi, CJD Ross, MR Hayden, BC Carleton, A Gaedigk, JS Leeder, ... Clinical Pharmacology & Therapeutics 85 (1), 31-35, 2009 | 378 | 2009 |
| Use of a microplate reader in an assay of glutathione reductase using 5, 5′-dithiobis (2-nitrobenzoic acid) AE Cribb, JS Leeder, SP Spielberg Analytical biochemistry 183 (1), 195-196, 1989 | 329 | 1989 |
| Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver X Yang, B Zhang, C Molony, E Chudin, K Hao, J Zhu, A Gaedigk, C Suver, ... Genome research 20 (8), 1020-1036, 2010 | 315 | 2010 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ... Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021 | 273 | 2021 |
| Unique CYP2D6 activity distribution and genotype‐phenotype discordance in black Americans A Gaedigk, LDA Bradford, KA Marcucci, JS Leeder Clinical pharmacology & therapeutics 72 (1), 76-89, 2002 | 253 | 2002 |
| Pharmacogenetics in pediatrics: implications for practice JS Leeder, GL Kearns Pediatric Clinics of North America 44 (1), 55-77, 1997 | 247 | 1997 |
| Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data A Gaedigk, RR Gotschall, NS Forbes, SD Simon, GL Kearns, JS Leeder Pharmacogenetics and Genomics 9 (6), 669-682, 1999 | 238 | 1999 |
| Newborn sequencing in genomic medicine and public health JS Berg, PB Agrawal, DB Bailey, AH Beggs, SE Brenner, AM Brower, ... Pediatrics 139 (2), 2017 | 228 | 2017 |
